Cardiovascular and metabolic outcome in 6-8 year old offspring of women with type 1 diabetes with near-optimal glycaemic control during pregnancy

被引:6
|
作者
Rijpert, Maarten [1 ]
Evers, Inge M. [2 ]
de Valk, Harold W. [3 ]
de Vroede, Monique A. M. J. [4 ]
Tersteeg-Kamperman, Marijke [1 ]
Heijnen, Cobi J. [1 ]
Visser, Gerard H. A. [1 ]
机构
[1] Univ Med Ctr Utrecht, Dept Obstet, Perinatal Ctr, NL-3508 AB Utrecht, Netherlands
[2] Meander Med Ctr, Dept Obstet & Gynaecol, Amersfoort, Netherlands
[3] Univ Med Ctr Utrecht, Dept Internal Med, NL-3508 AB Utrecht, Netherlands
[4] Univ Med Ctr Utrecht, Dept Paediat Endocrinol, NL-3508 AB Utrecht, Netherlands
关键词
Type; 1; diabetes; Pregnancy; Follow-up; Child development; Cardiovascular disease; Metabolic Syndrome; BLOOD-PRESSURE; GLUCOSE-TOLERANCE; OVERWEIGHT; CHILDREN; MOTHERS; OBESITY; CHILDHOOD; DEFINITION; MELLITUS; INFANTS;
D O I
10.1016/j.earlhumdev.2010.10.002
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: High maternal glucose concentrations during diabetic pregnancy may lead to health problems in the offspring later in life. We showed in a previous nationwide study on pregnancy outcome in type 1 diabetic women that prepregnancy care was good and a near-optimal glycaemic control during pregnancy was achieved (mean HbA1c 6.2%). Aims: We investigated to what extent current care and treatment of pregnant women with type 1 diabetes were related to cardiovascular and metabolic disturbances in the offspring at school age. Additionally, we studied the influence of level of maternal glycaemic control, preterm birth and neonatal macrosomia (birth weight>p90). Study design: Observational cohort study. Subjects: 6-8 year old offspring of women with type 1 diabetes (ODM, n = 213) and a control group of children of non-diabetic women (n = 79). Outcome measures: BMI, blood pressure, parameters of fasting glucose regulation and lipid metabolism, components of the metabolic syndrome (overweight, hypertension, impaired fasting glucose, dyslipidaemia). Results: Parameters of fasting glucose regulation and lipid metabolism and the frequency of components of the metabolic syndrome did not significantly differ between ODM and controls. Systolic blood pressure was slightly higher in ODM. The influence of level of maternal glycaemic control, preterm birth and neonatal macrosomia on outcome in ODM was limited. Conclusions: Current care and treatment of pregnant women with type 1 diabetes result in cardiovascular and metabolic outcome in the offspring at 6-8 years of age that is comparable to that in children of non-diabetic women. Further follow-up should substantiate these results at later age. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:49 / 54
页数:6
相关论文
共 12 条
  • [1] Cognitive function in 6 to 12 year old offspring of women with type 1 diabetes
    Temple, R. C.
    Hardiman, M.
    Martinez, M.
    Pellegrin, M.
    DIABETOLOGIA, 2008, 51 : S417 - S418
  • [2] Cognitive function in 6-to 12-year-old offspring of women with Type 1 diabetes
    Temple, R. C.
    Hardiman, M.
    Pellegrini, M.
    Horrocks, L.
    Martinez-Cengotitabengoa, M. -T.
    DIABETIC MEDICINE, 2011, 28 (07) : 845 - 848
  • [3] Treatment with the long-acting insulin analogues detemir or glargine during pregnancy in women with type 1 diabetes: comparison of glycaemic control and pregnancy outcome
    Callesen, Nicoline F.
    Damm, Julie
    Mathiesen, Jonathan M.
    Ringholm, Lene
    Damm, Peter
    Mathiesen, Elisabeth R.
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2013, 26 (06): : 588 - 592
  • [4] Dietary Advice to Support Glycaemic Control and Weight Management in Women with Type 1 Diabetes during Pregnancy and Breastfeeding
    Ringholm, Lene
    Norgaard, Sidse Kjaerhus
    Rytter, Ane
    Damm, Peter
    Mathiesen, Elisabeth Reinhardt
    NUTRIENTS, 2022, 14 (22)
  • [5] Pens or pumps for optimal glycaemic control during pregnancy: an analysis of 598 Type 1 diabetes pregnancies from the 2013 National Pregnancy in Diabetes audit
    Murphy, H. R.
    Curnow, P.
    Cartright, C.
    Bell, R.
    Maresh, M.
    Lewis-Barned, N.
    DIABETIC MEDICINE, 2016, 33 : 168 - 168
  • [6] Near-optimal glycemic control in Chilean women with pregestational type-2 diabetes: Persistent macrosomia relates to maternal pre-pregnancy overweight
    Olmos, Pablo R.
    Araya-Del-Pino, Andrea P.
    Gonzalez-Carvello, Cristian A.
    Laso-Ulloa, Pablo
    Hodgson, Maria I.
    Irribarra, Veronica
    Borzone, Gisella R.
    Belmar, Cristian
    Poblete, Andres
    Berrios, Cecilia
    Becker, Jorge
    Zajer-Amar, Claudia M.
    Manzur, Alejandro
    Bozinovic, Milan
    Miranda, Ramon J.
    Diez, Alberto
    Vidal, Hernan
    Ramirez-Armijo, Renato
    Olmos, Roberto I.
    Tabilo, Cristian
    Ahuad, Jessica
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 85 (01) : 53 - 60
  • [7] Thyroid peroxidase antibodies in pregnant women with type 1 diabetes: Impact on thyroid function, metabolic control and pregnancy outcome
    Vestgaard, Marianne
    Nielsen, Lene Ringholm
    Rasmussen, Ase Krogh
    Damm, Peter
    Mathiesen, Elisabeth R.
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2008, 87 (12) : 1336 - 1342
  • [8] Both glycaemic control and insulin dose during pregnancy in women with type 1 diabetes are associated with neonatal anthropometric measures and placental weight
    Garcia-Patterson, Apolonia
    Ovejero, Diana
    Minambres, Inka
    Chico, Ana
    Alejandro Gil, Pedro
    Martinez, Maria-Jose
    Maria Adelantado, Juan
    de Leiva, Alberto
    Gich, Ignasi
    Desoye, Gernot
    Hauguel de Mouzon, Sylvie
    Corcoy, Rosa
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2020, 36 (05)
  • [9] Glycaemic control during pregnancy in women with long duration type 1 diabetes: lessons learnt using continuous glucose monitoring systems
    Temple, R. C.
    Duffield, K.
    Lewis, K.
    Murphy, H. R.
    DIABETOLOGIA, 2006, 49 : 578 - 579
  • [10] REAL-TIME CONTINUOUS GLUCOSE MONITORING DURING PREGNANCY IN WOMEN WITH TYPE 1 DIABETES: IS RTCGM RELATED TO BETTER GLYCAEMIC CONTROL AND KEY OBSTETRIC OUTCOMES?
    Geelhoed-Duijvestijn, P.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A27 - A27